Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lovedeep Gondara

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Current Oncology (Toronto, Ont.)|June 23, 2022
Willingness to Self-Collect a Sample for HPV-Based Cervical Cancer Screening in a Well-Screened Cohort: HPV FOCAL Survey ResultsAnne Lesack, Laurie W Smith, C Sarai Racey, et al.
International Journal of Cancer|April 23, 2022
Human papillomavirus-based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trialAnna Gottschlich, Lovedeep Gondara, Laurie W Smith, et al.
JAMA Network Open|March 11, 2026
HPV, Cytology, and Cotest Cervical Cancer Screening and the Risk of PrecancerAnna Gottschlich, Laurie W Smith, Quan Hong, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 21, 2020
Assessing 10-Year Safety of a Single Negative HPV Test for Cervical Cancer Screening: Evidence from FOCAL-DECADE CohortAnna Gottschlich, Dirk van Niekerk, Laurie W Smith, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|February 18, 2026
Loop electrosurgical excision procedure and perinatal outcomes post-human papillomavirus cervical screening: A longitudinal cohort studyQuan Hong, Laurie W Smith, Lily Proctor, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 19, 2016
Aptima HPV Assay versus Hybrid Capture<sup>®</sup> 2 HPV test for primary cervical cancer screening in the HPV FOCAL trialDarrel A Cook, Laurie W Smith, Jennifer Law, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 18, 2018
Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trialDarrel A Cook, Laurie W Smith, Jennifer H Law, et al.
International Journal of Cancer|September 30, 2016
HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancerGina S Ogilvie, Mel Krajden, Dirk van Niekerk, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 22, 2024
Evidence of Decreased Long-term Risk of Cervical Precancer after Negative Primary HPV Screens Compared with Negative Cytology Screens in a Longitudinal Cohort StudyAnna Gottschlich, Quan Hong, Lovedeep Gondara, et al.
Lancet Regional Health. Americas|October 3, 2023
Colposcopy referral rates post-introduction of primary screening with human papillomavirus testing: evidence from a large British Columbia cohort studyAnna Gottschlich, Lovedeep Gondara, Laurie W Smith, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Current Oncology (Toronto, Ont.)|June 23, 2022
Willingness to Self-Collect a Sample for HPV-Based Cervical Cancer Screening in a Well-Screened Cohort: HPV FOCAL Survey ResultsAnne Lesack, Laurie W Smith, C Sarai Racey, et al.
International Journal of Cancer|April 23, 2022
Human papillomavirus-based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trialAnna Gottschlich, Lovedeep Gondara, Laurie W Smith, et al.
JAMA Network Open|March 11, 2026
HPV, Cytology, and Cotest Cervical Cancer Screening and the Risk of PrecancerAnna Gottschlich, Laurie W Smith, Quan Hong, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 21, 2020
Assessing 10-Year Safety of a Single Negative HPV Test for Cervical Cancer Screening: Evidence from FOCAL-DECADE CohortAnna Gottschlich, Dirk van Niekerk, Laurie W Smith, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|February 18, 2026
Loop electrosurgical excision procedure and perinatal outcomes post-human papillomavirus cervical screening: A longitudinal cohort studyQuan Hong, Laurie W Smith, Lily Proctor, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 19, 2016
Aptima HPV Assay versus Hybrid Capture<sup>®</sup> 2 HPV test for primary cervical cancer screening in the HPV FOCAL trialDarrel A Cook, Laurie W Smith, Jennifer Law, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 18, 2018
Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trialDarrel A Cook, Laurie W Smith, Jennifer H Law, et al.
International Journal of Cancer|September 30, 2016
HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancerGina S Ogilvie, Mel Krajden, Dirk van Niekerk, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 22, 2024
Evidence of Decreased Long-term Risk of Cervical Precancer after Negative Primary HPV Screens Compared with Negative Cytology Screens in a Longitudinal Cohort StudyAnna Gottschlich, Quan Hong, Lovedeep Gondara, et al.
Lancet Regional Health. Americas|October 3, 2023
Colposcopy referral rates post-introduction of primary screening with human papillomavirus testing: evidence from a large British Columbia cohort studyAnna Gottschlich, Lovedeep Gondara, Laurie W Smith, et al.
Pageof 6